Navigation Links
BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its 2012 Annual Report
Date:3/18/2013

groups.  The trials are expected to complete in late 2013 or early 2014.  Upon completion of study enrollment and database lock for each trial, and the acceptance of filing of the NDA with the FDA, BDSI is expected to receive milestone payments from Endo totaling $30 million. 
  • BUNAVAIL commercialization opportunities.  BDSI will continue to evaluate its strategic options for the commercialization of BUNAVAIL, which include partnership, internal approaches or a combination of these.  BDSI expects to finalize its strategy in the second half of 2013.
  • Re-introduction of ONSOLIS in the U.S.  In March 2013, BDSI and Meda submitted a proposal to FDA to reintroduce ONSOLIS into the U.S. marketplace following previously reported appearance issues with the product.  If approved by FDA, the original ONSOLIS formulation may be on the market during the second-half of this year while stability data is collected on a newly formulated version of ONSOLIS.  These data may be submitted to FDA before the end of the year, and if approved, could allow introduction of the new formulation sometime in 2014.
  • Exploration of potential new products and technologies.  In addition to advancing its lead products in development, BDSI is also, as in the past, exploring the application of its BEMA drug delivery technology to additional pharmaceuticals.  In addition, BDSI has been investigating potential new products and technologies to complement and diversify its existing portfolio. 
  • About BioDelivery Sciences International
    BioDelivery Sciences International (NASDAQ: BDSI) is a specialty pharmaceutical company that is leveraging its novel and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties, new applications of pro
    '/>"/>

    SOURCE BioDelivery Sciences International, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. BioDelivery Sciences Announces Positive Results from BEMA Buprenorphine/Naloxone (BNX) Pharmacokinetic Study
    2. BioDelivery Sciences and Endo Health Solutions Announce Initiation of Enrollment in the Phase 3 Program for BEMA Buprenorphine for Chronic Pain
    3. BioDelivery Sciences to Present at the 2012 Wedbush PacGrow Lifesciences Management Access Conference
    4. BioDelivery Sciences Announces Completion of Enrollment in Pivotal Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone
    5. BioDelivery Sciences to Present at the Stifel Nicolaus 2012 Healthcare Conference
    6. BioDelivery Sciences Announces Positive Results of Pivotal Pharmacokinetic Study Comparing BEMA Buprenorphine/Naloxone (BNX) to Suboxone
    7. BioDelivery Sciences Provides Business Update and Summary of Third Quarter Results of Operations
    8. BioDelivery Sciences to Present at the 24th Annual Piper Jaffray Healthcare Conference
    9. BioDelivery Sciences Announces $40 Million Registered Financing
    10. BioDelivery Sciences Announces Completion of BNX Safety Study
    11. BioDelivery Sciences to Present at the 15th Annual BIO CEO and Investor Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/10/2014)... 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... completed the sale to Galderma of all rights to ... by Valeant for $1.4 billion in cash, pursuant to ... completed its acquisition of Galderma. "We ... to a company that is firmly committed to the ...
    (Date:7/10/2014)... , July 10, 2014 Decision Resources Group ... of the U.S. Food and Drug Administration,s (FDA) approval ... binder Velphoro, which was approved by the FDA in ... kidney disease (CKD) patients on dialysis. Other ... Nephrology (US) Q2 2014 : ...
    (Date:1/15/2014)... As health officials across the Midwest warn against the widespread ... Michigan will offer free diagnostic testing for ... to administer tests and, in some cases, fill the matching ... the study. The Grand Rapids, Mich. ...
    Breaking Medicine Technology:Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3
    ... Ala., Nov. 9 Surgical Care Affiliates ("SCA") today ... at 11:00 a.m. Eastern Time on Monday, November 16, ... A 30-day replay will be available approximately an ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080812/CLTU111LOGO ) ...
    ... Mass., Nov. 9 Boston Scientific Corporation (NYSE: ... the 38th annual Global Congress for Minimally Invasive Gynecology ... Results from two clinical studies will be presented ... systems and mid-urethral sling systems used to treat pelvic ...
    Cached Medicine Technology:Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 2Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 3Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 4Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 5
    (Date:7/11/2014)... July 11, 2014 Wild by Nature, a ... to announce they are opening a fifth store to be ... Nature offers one of the largest selections of wheat and ... with celiac disease, these stores have become a one-stop shop ... , Gluten sensitivity, and gluten intolerance, is a spectrum of ...
    (Date:7/11/2014)... This is a professional and in-depth ... industry in Global and China. The report provides ... applications and industry chain structure. Global market analysis ... a focus on history, developments, trends and competitive ... international and Chinese situation is also offered. , ...
    (Date:7/11/2014)... Beach, CA (PRWEB) July 11, 2014 ... pure Artichoke Leaf Extract dietary supplements to aid in ... an action necessary to facilitate metabolism of fat. Formulated ... Superior Labs Artichoke Leaf Extract is available in all-natural, ... pure artichoke extract. , Health Benefits of Artichoke ...
    (Date:7/11/2014)... Latham, New York (PRWEB) July 11, 2014 ... imaging as an integral part of each patient’s unique ... detailed analysis of the skin’s health and trouble areas ... a personalized aesthetic plan to be established. , Vectra ... during the consultation appointment, Vectra 3D uses a quick ...
    (Date:7/11/2014)... (PRWEB) July 11, 2014 ... email management with its unique Netmail Platform, today ... World Partner Conference (WPC), which will be held ... July 13-17, 2014. During the show, Netmail will ... email management solution that consolidates email security, archiving, ...
    Breaking Medicine News(10 mins):Health News:Wild by Nature Opens New Location 2Health News:Cholesterol Industry 2014 Development Trends in Global & China Regions in a New Research Study Available at DeepResearchReports.com 2Health News:Cholesterol Industry 2014 Development Trends in Global & China Regions in a New Research Study Available at DeepResearchReports.com 3Health News:Artichoke Leaf Extract Released by SuperiorLabs Now Available on Amazon.com With 2 Day Prime Shipping 2Health News:Artichoke Leaf Extract Released by SuperiorLabs Now Available on Amazon.com With 2 Day Prime Shipping 3Health News:Williams Rejuva Center Includes Innovative Computer Imaging 2Health News:Netmail Heads to Washington, D.C. to Demonstrate New Release of Netmail 5.3 at WPC 2014 July 13-17, 2014 2Health News:Netmail Heads to Washington, D.C. to Demonstrate New Release of Netmail 5.3 at WPC 2014 July 13-17, 2014 3
    ... weight-loss medication orlistat (marketed by GlaxoSmithKline as Xenical? 120 ... in overweight individuals,// according to new data presented today ... Society in Vancouver, British Columbia. ,The study, ... plus diet in patients with a body mass index ...
    ... The body responds to a diverse range of insults, ... of a wide range of cell types of the ... and mediators.// The inflammatory response, although essential for fighting ... pro- and anti-inflammatory mediators, cytokines and lipid mediators being ...
    ... New research suggests that cannabis smokers are at less ... chemical structures of marijuana and tobacco are strikingly similar, ... while cannabis contains tetrahydrocannabinol (THC, the active ingredient in ... inhibit the carcinogenic properties of some other chemicals. This ...
    ... government has been warned against suspected carriers of the dreaded ... to raise awareness in the State. //More than 60 people ... in the Southeast Asia since 2003.,"The central government has alerted ... specially from Southeast Asia and China," said D.S. Narve, the ...
    ... traditional cholecystectomy, and represents the gold standard for ... remains the most serious //complication of cholecystectomy. According ... issue of the journal Archives of Surgery, the ... LC. The study verifies the current incidence, ...
    ... development of kidney disease and is the leading cause ... pre-diabetes is associated with the development of kidney disease ... kidney function are present early on among subjects with ... the progression of kidney disease. Recently, researchers, writing in ...
    Cached Medicine News:Health News:Weight-Loss Medication Evaluated By Nutrition Expert 2Health News:The ideal composition of intravenous lipid emulsion 2Health News:Higher incidence of bile duct injury during laparoscopic cholecystectomy 2Health News:Development of kidney disease in adults with pre-diabetes 2
    ... CryoCath has developed a minimally ... reentrant tachycardia. It delivers a very ... site confirmation, pinpoint site precision, minimal ... thrombus and stenosis., ,Freezor is a ...
    The Medtronic CardioRhythm Marinr Catheter is intended for use in diagnostic electrophysiologic procedures. These catheters are designed for recording intracardiac electrograms and temporary pacing a...
    ... catheter is specifically designed for use with ... EP deflectable NAVI-STAR catheter houses a Biosense ... indicate, in real time, exact location points ... local electrogram information. The NAVI-STAR electro-anatomical navigation ...
    For Atrial Mapping. Biosense Webster offers a complete line of specialty 20-pole catheters. The CRISTA CATH 20-pole deflectable catheter is designed for positioning along the crista terminals....
    Medicine Products: